Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro

B Barut1, D Chauhan, H Uchiyama

  • 1Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.

Insights

Interleukin-6 (IL-6) does not directly drive hairy cell leukemia (HCL) growth. However, IL-6 mediates tumor necrosis factor (TNF)-induced HCL DNA synthesis through an intracellular pathway.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Hairy cell leukemia (HCL) is a rare B-cell malignancy.
  • The role of interleukin-6 (IL-6) in HCL proliferation is not fully understood.

Purpose of the Study:

  • To investigate the direct and indirect roles of IL-6 in HCL cell growth.
  • To determine if tumor necrosis factor (TNF)-induced HCL proliferation is IL-6-dependent.

Main Methods:

  • Purified HCL cells were cultured in vitro.
  • DNA synthesis was measured using various assays.
  • IL-6 receptor (IL-6R) expression and IL-6 binding were assessed.
  • IL-6 mRNA and protein levels were analyzed by Northern blotting and PCR.
  • Neutralizing antibodies and antisense oligonucleotides were employed.

Main Results:

  • Exogenous IL-6 did not stimulate HCL DNA synthesis.
  • HCL cells expressed IL-6R and secreted low levels of IL-6.
  • TNF significantly enhanced HCL DNA synthesis.
  • TNF treatment increased IL-6 mRNA and protein production in HCL cells.
  • IL-6 antisense oligonucleotide inhibited TNF-induced DNA synthesis and IL-6 secretion.

Conclusions:

  • IL-6 does not directly promote HCL growth.
  • IL-6 plays an indirect role in mediating TNF-induced HCL proliferation.
  • An intracellular mechanism involving IL-6 mediates TNF's effect on HCL DNA synthesis.